Transce3nd, LLC Axsome Therapeutics, Inc. Transaction History
Transce3nd, LLC
- $295 Billion
- Q4 2024
A detailed history of Transce3nd, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Transce3nd, LLC holds 134 shares of AXSM stock, worth $17,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134Holding current value
$17,164% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
350Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$519 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$500 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$423 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$188 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$178 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.49B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...